RNA Supply Chain Resources

  1. The Key To Improving Global Supply Chain Resilience 6/10/2024

    Explore the past, present, and future of supply chain security, ways the biopharma industry can secure supply chains and minimize risks, and more.

  2. Advancing mRNA Therapeutics With High Performance RNA Polymerases 2/9/2026

    Learn how optimized RNA polymerases enhance mRNA therapeutic quality and transcript integrity by increasing yield and capping efficiency while reducing double-stranded RNA impurities.

  3. Where Can Novel Non-Viral Polymeric Delivery Agents Take Us? 1/18/2023

    Explore ongoing work to harness different types of HDR templates in order to build cutting-edge systems with the potential to enable point-of-care cell and gene therapy manufacture.

  4. Integrate Cryopreservation Into the End-To-End Supply Chain 5/28/2026

    Cryopreservation should be integrated across the entire supply chain to ensure traceability, reduce risk at handoffs, and support consistent, scalable therapy development and delivery.

  5. Accelerate Efficiency By Decoupling Collection From Manufacturing 6/26/2026

    Cryopreservation eliminates rigid timelines by decoupling collection from production, providing the flexibility needed to optimize facility use and stabilize advanced therapy supply chains.

  6. The Role Of CRISPR Cas9 Plasmids In Gene-Editing 12/12/2023

    Plasmids are crucial for CRISPR-Cas9 gene-editing technology, and their role in CRISPR is expected to evolve with ongoing research.

  7. Gene And Cell Therapy: Planning For Manufacturing Success Early 1/16/2023

    As gene therapy organizations are asked to balance the need for rapid clinical progression and stringent quality expectations, explore how to optimize plasmid production and reach patients with efficiency.

  8. Reducing Lead Time, Delivering >99.5% OTIF 1/23/2024

    Explore the stocking solution offered to a mid-sized CDMO in need of a high volume of safety stock inventory to support their customer portfolio growth.

  9. Optimization Of Transient Transfection Of MSCs With Plasmid DNA Or mRNA 11/1/2022

    Read through the results of our efforts to produce an optimal protocol for the transient transfection of hMSCs with pDNA or mRNA using non-viral means.

  10. Overcome The Supply Chain Complexities Of Vaccine Development 11/18/2022

    Explore the industry impact of rapidly evolving vaccinology, the power of next-gen science and technology, and how finding the right supply chain partner has never been more essential.